Pacific Bio (PACB) Tops Q1 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $39.98 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• ADP Employment Change (Aug) 38K vs 47K Expected
• Contango Silver & Gold reports high-grade gold hits at Lucky Shot
• Li Auto launches new Li MEGA MPV priced at RMB509,800